Clinical Trials Browser

Phase 2 × Breast Cancer Metastatic × trastuzumab deruxtecan × Clear all

NCT06750484 2026-02-27

Trial of Trastuzumab Deruxtecan in Previously Treated HER2

Phase 2 Recruiting

Breast Cancer Metastatic